List of insiders holdings for Kymera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
2024-08-22 17:06:14 | 6,392,200 100,190 |
6,492,390 | Form 4 |
| 2 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
2024-08-22 16:15:37 | 6,001,262 0 |
6,001,262 | Form 13D |
| 3 | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
2024-11-14 16:31:20 | 4,173,216 0 |
4,173,216 | Form 13G |
| 4 | Redmile Group LLC Green Jeremy 10% Owner |
2023-02-14 16:27:49 | 2,673,837 0 |
2,673,837 | Form 13G |
| 5 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
2020-08-27 16:12:15 | 959,211 0 |
959,211 | Form 4 |
| 6 | Booth Bruce Director |
2024-07-09 17:15:28 | 0 723,246 |
723,246 | Form 4 |
| 7 | Alexandria Venture Investments LLC 10% Owner |
2020-08-25 18:36:17 | 467,932 0 |
467,932 | Form 4 |
| 8 | Mainolfi Nello Chief Executive Officer |
2025-03-03 18:30:03 | 365,000 0 |
365,000 | Form 4 |
| 9 | Jacobs Bruce N. Chief Financial Officer |
2025-04-01 08:00:03 | 296,785 0 |
296,785 | Form 4 |
| 10 | Chesworth Richard Chief Scientific Officer |
2021-08-27 16:55:43 | 263,340 0 |
263,340 | Form 4 |
| 11 | Gollob Jared Chief Medical Officer |
2025-03-03 18:30:03 | 180,000 0 |
180,000 | Form 4 |
| 12 | Goodman Noah Chief Business Officer |
2025-04-09 08:05:05 | 150,081 0 |
150,081 | Form 4 |
| 13 | Chiniara Ellen Chief Legal Officer |
2025-03-03 18:30:08 | 135,085 0 |
135,085 | Form 4 |
| 14 | Chadwick Jeremy G Chief Operating Officer |
2025-03-03 18:30:06 | 117,800 0 |
117,800 | Form 4 |
| 15 | Caughey Elaine Chief Business Officer |
2023-03-03 16:31:17 | 82,324 0 |
82,324 | Form 4 |
| 16 | Hedin Andrew Director |
2020-08-21 18:23:43 | 40,127 0 |
40,127 | Form 4 |
| 17 | Horobin Joanna Director |
2024-06-07 18:36:33 | 33,195 0 |
33,195 | Form 4 |
| 18 | Esposito Pamela Director |
2024-12-02 19:50:40 | 29,127 0 |
29,127 | Form 4 |
| 19 | Hall Steven Edward Director |
2021-06-17 16:43:23 | 20,063 0 |
20,063 | Form 4 |
| 20 | MARAGANORE JOHN Director |
2024-06-20 17:00:08 | 16,000 0 |
16,000 | Form 4 |
| 21 | Hrustanovic Gorjan Director |
2024-06-20 17:00:10 | 16,000 0 |
16,000 | Form 4 |
| 22 | Ridloff Elena Director |
2024-06-20 17:00:11 | 16,000 0 |
16,000 | Form 4 |
| 23 | Morgan Leigh Director |
2024-06-20 17:00:07 | 16,000 0 |
16,000 | Form 4 |
| 24 | Sandor Victor Director |
2024-06-20 17:00:03 | 16,000 0 |
16,000 | Form 4 |
| 25 | Nicholson Donald William Director |
2022-06-16 16:06:10 | 12,000 0 |
12,000 | Form 4 |
| 26 | Albers Jeffrey W. Director |
2024-08-26 18:31:05 | 11,349 0 |
11,349 | Form 4 |